IL17A and colitis: Investigation of the reason for this increased resistance to induction of experimental colitis disclosed that whereas increased IL-1β secretion due to the mutation led to increased IL-1β secretion(and IL-17 production as well) as expected from the presence of the inflammasome mutation, it was accompanied by decreased production of other pro-inflammatory mediators.